Skip to content

STERIS STE Life Sciences: — Revenue

Other segment segments

Healthcare Segment
$1.14B+7.5%
AST
$289.2M+5.6%

Similar metrics at other companies

VAT
VATELife Sciences — Total Revenue
$1.6M-48.4%
Clarivate logo
CLVTLife Sciences & Healthcare — Revenue
$93.3M-5.1%
Revvity logo
RVTYLife Sciences — Segment revenue
$361.85M+6.3%
Danaher logo
DHRLife Sciences — Sales
$1.74B+3.4%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Consolidated revenues
$2.64B+12.6%
Donaldson Company logo
DCILife Sciences Segment — Net Sales
$83.5M+12.5%

Other financials

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total equity$7.2B+8.8%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%
Free cash flow$245.2M+29.1%

Valuation

See full
Market cap$20.52B-9.4%
Enterprise value$22.17B-8.8%
P/E26.2×-8.8×
P/S3.5×-0.6×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: STERIS’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's life sciences: — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is STERIS's life sciences: — revenue?
STERIS (STE) reported life sciences: — revenue of $145.8M in Q4 2025.
What does life sciences: — revenue mean?
This metric represents the total revenue generated from the Life Sciences business segment, which provides sterilization and decontamination solutions to pharmaceutical and research customers. It reflects the market demand for specialized equipment and services used in critical biopharma manufacturing environments.